{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:14:19Z","timestamp":1787242459721,"version":"build-2736575974"},"reference-count":28,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"unspecified","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004417","name":"Global Fund to Fight AIDS, Tuberculosis and Malaria","doi-asserted-by":"publisher","award":["TZA-H-MOF\/1573"],"award-info":[{"award-number":["TZA-H-MOF\/1573"]}],"id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,11,23]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Tanzania is making an enormous effort in scaling-up of antiretroviral therapy (ART). However, people living with HIV (PLHIV) continue to succumb to the challenge of drug resistance. Evidence on drug resistance for a national survey is unavailable in Tanzania. Therefore, we sought to assess viral suppression (vs) rates and magnitude of acquired drug resistance (ADR) among PLHIV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A national survey will be conducted from 26 July to 29 October 2021 in 22 regions, recruiting 2160 participants. These will include adults on ART for 9\u201315 months and \u226548 months and children on ART for 9\u201315 months and \u226536 months. A standardised questionnaire will capture participants\u2019 demographic and clinical data. Plasma and dried blood spot will be prepared for viral load testing and drug resistance genotyping. Statistical analyses to determine the burden of ADR, characteristics and factors associated therewith will be done using STATA V.15.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval has been obtained from the National Health Research Ethics Committee of Tanzania (NIMR\/HQ\/R.8a\/Vol.IX\/3432). Appropriate participant informed consent or parental consent and assent will be obtained. Dissemination will include a survey report, conference presentations, policy briefs and peer-reviewed publications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-054021","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T12:26:29Z","timestamp":1639743989000},"page":"e054021","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Acquired HIV drug resistance among children and adults receiving antiretroviral therapy in Tanzania: a national representative survey protocol"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6939-5125","authenticated-orcid":false,"given":"Joan","family":"Rugemalila","sequence":"first","affiliation":[{"name":"Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Kamori","sequence":"additional","affiliation":[{"name":"Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Maokola","sequence":"additional","affiliation":[{"name":"Strategic Information Unit, National AIDS Control Program, Dodoma, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mucho","family":"Mizinduko","sequence":"additional","affiliation":[{"name":"Epidemiology and Biostatistics, Muhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey","family":"Barabona","sequence":"additional","affiliation":[{"name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto-Shi, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Masoud","sequence":"additional","affiliation":[{"name":"Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B","family":"Mlunde","sequence":"additional","affiliation":[{"name":"Department of Community Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8963-4920","authenticated-orcid":false,"given":"Ritah Francis","family":"Mutagonda","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Pharmacology, Muhimbili University of Health and Allied Sciences, Dar-es-salaam, Tanzania, United Republic of Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Ruhago","sequence":"additional","affiliation":[{"name":"Department of Development Studies, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Mushi","sequence":"additional","affiliation":[{"name":"Strategic Information Unit, National AIDS Control Program, Dodoma, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veryeh","family":"Sambu","sequence":"additional","affiliation":[{"name":"Strategic Information Unit, National AIDS Control Program, Dodoma, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4852-4236","authenticated-orcid":false,"given":"Takamasa","family":"Ueno","sequence":"additional","affiliation":[{"name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto-Shi, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Mutayoba","sequence":"additional","affiliation":[{"name":"Administration Department, National AIDS Control Program, Dodoma, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosper","family":"Njau","sequence":"additional","affiliation":[{"name":"Strategic Information Unit, National AIDS Control Program, Dodoma, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tumaini","family":"Nagu","sequence":"additional","affiliation":[{"name":"Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Aboud","sequence":"additional","affiliation":[{"name":"Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-0725","authenticated-orcid":false,"given":"Bruno F","family":"Sunguya","sequence":"additional","affiliation":[{"name":"Department of Community Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"2025121410270788000_11.12.e054021.1","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-09361-6","article-title":"Art use and associated factors among HIV positive caregivers of orphans and vulnerable children in Tanzania","volume":"20","author":"Exavery","year":"2020","journal-title":"BMC Public Health"},{"key":"2025121410270788000_11.12.e054021.2","unstructured":"Tanzania HIV Impact Survey . A population based HIV impact assessment 2016-2017. Available: https:\/\/www.nbs.go.tz\/nbs\/takwimu\/this2016-17\/Tanzania_SummarySheet_English.pdf [Accessed 15 May 2020]."},{"key":"2025121410270788000_11.12.e054021.3","unstructured":"UNAIDS . Global HIV & AIDS statistics \u2014 2019 fact sheet, 20192020. Available: https:\/\/www.unaids.org\/en\/resources\/fact-sheet [Accessed 13 Jun 2020]."},{"key":"2025121410270788000_11.12.e054021.4","unstructured":"AVERT . HIV and AIDS in Tanzania [report], 2020. Available: https:\/\/www.avert.org\/printpdf\/node\/40615\/05\/2021 [Accessed 15 May 2021]."},{"key":"2025121410270788000_11.12.e054021.5","doi-asserted-by":"publisher","DOI":"10.2174\/187152611795589663"},{"key":"2025121410270788000_11.12.e054021.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-020-00294-z","article-title":"Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia","volume":"17","author":"Nega","year":"2020","journal-title":"AIDS Res Ther"},{"key":"2025121410270788000_11.12.e054021.7","first-page":"229","article-title":"Antiretroviral treatment failure and associated factors among HIV-infected children on antiretroviral therapy: a retrospective study","volume":"13","author":"Getawa","year":"2021","journal-title":"HIV Aids"},{"key":"2025121410270788000_11.12.e054021.8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/tmi.12507","article-title":"Immunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data","volume":"20","author":"Vanobberghen","year":"2015","journal-title":"Trop Med Int Health"},{"key":"2025121410270788000_11.12.e054021.9","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001273"},{"key":"2025121410270788000_11.12.e054021.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232649","article-title":"Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania","volume":"15","author":"Mziray","year":"2020","journal-title":"PLoS One"},{"key":"2025121410270788000_11.12.e054021.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-3871-0","article-title":"HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon","volume":"19","author":"Takou","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2025121410270788000_11.12.e054021.12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220159"},{"key":"2025121410270788000_11.12.e054021.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-05491-9","article-title":"Genotype-Informed versus empiric management of viremia (give move): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania","volume":"20","author":"Brown","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2025121410270788000_11.12.e054021.14","unstructured":"National AIDS Control Programme . National guidelines for management of HIV and AIDS. 181. 6th ed, 2017."},{"key":"2025121410270788000_11.12.e054021.15","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1016\/S2352-3018(18)30093-6","article-title":"Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research","volume":"5","author":"Dorward","year":"2018","journal-title":"Lancet HIV"},{"key":"2025121410270788000_11.12.e054021.16","unstructured":"World Health Organization . WHO manual for HIV drug resistance testing using dried blood spot specimens, 2020. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240009424 [Accessed 30 Nov 2020]."},{"key":"2025121410270788000_11.12.e054021.17","doi-asserted-by":"publisher","DOI":"10.1159\/000331998"},{"key":"2025121410270788000_11.12.e054021.18","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu079"},{"key":"2025121410270788000_11.12.e054021.19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/tmi.12804","article-title":"Treatment outcomes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa","volume":"22","author":"Shearer","year":"2017","journal-title":"Trop Med Int Health"},{"key":"2025121410270788000_11.12.e054021.20","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-017-0145-z"},{"key":"2025121410270788000_11.12.e054021.21","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2013.s1.e5"},{"key":"2025121410270788000_11.12.e054021.22","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit107"},{"key":"2025121410270788000_11.12.e054021.23","article-title":"Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus study, Dar ES Salaam, Tanzania","volume":"15","author":"Matilda Ngarina","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2025121410270788000_11.12.e054021.24","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-020-0261-z","article-title":"Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria","volume":"17","author":"Ekong","year":"2020","journal-title":"AIDS Res Ther"},{"key":"2025121410270788000_11.12.e054021.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129210","article-title":"Monitoring HIV drug resistance early warning indicators in Cameroon: a study following the revised World Health organization recommendations","volume":"10","author":"Fokam","year":"2015","journal-title":"PLoS One"},{"key":"2025121410270788000_11.12.e054021.26","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw011"},{"key":"2025121410270788000_11.12.e054021.27","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001536"},{"key":"2025121410270788000_11.12.e054021.28","unstructured":"Organization WH . HIV drug resistance report 2019, 2019."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-054021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:27:17Z","timestamp":1765736837000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-054021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,17]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/bmjopen-2021-054021"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-054021","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}